Ticker: RXRX

Company: RECURSION PHARMACEUTICALS, INC.

Person: Christopher Gibson, director, officer

Transaction date: Nov. 15, 2024

Reporting date: Nov. 19, 2024

Average share price: 6.175

Sold 26023.0 shares for 160692.03